EVIO Inc. Announces California’s Phase 3 Cannabis Testing
December 03, 2018 at 01:00 pm
Share
EVIO Inc. announced it now meets California’s Phase 3 cannabis compliance testing requirements. Starting January 1, 2019, the Bureau of Cannabis Control requires additional testing for terpenoids, mycotoxins, heavy metals and water activity. The regulations set forth by the BCC requires licensed retailers to only sell cannabis goods that have met all state-mandated testing requirements. EVIO Labs Berkeley is one of the first of California’s fully ISO 17025-accredited labs prepared to offer Phase 3 compliance testing. The lab has continued to realize an increased demand for its services and is preparing for the additional projected increase in volume by expanding the lab.
EVIO, Inc. is a diversified holding company. The Company provides analytical testing services to the agricultural and pharmaceutical industries, primarily for cannabis, hemp, and related products. The Company offers residential and commercial construction services. The Company also offers research and development and consulting services for participants in the cannabis and hemp industries. The Company tests products to verify the regulatory requirements for sale. Its subsidiaries include Smith Scientific Industries, LLC; Greenhaus Analytical Labs, LLC; Viridis Analytics, LLC; EVIO Labs OR, Inc.; C3 Labs, LLC; EVIO Labs Humboldt, LLC and Keystone Labs, Inc.